Report cover image

North America Pen Needles Market Size, Share & Industry Trends Analysis Report By Type, By Setting, By Application, By Length (8mm, 6mm, 5mm, 10mm, 12mm, and 4mm), By Mode of Purchase, By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Oct 31, 2023
Length 178 Pages
SKU # KBV18339177

Description

North America Pen Needles Market Size, Share & Industry Trends Analysis Report By Type, By Setting, By Application, By Length (8mm, 6mm, 5mm, 10mm, 12mm, and 4mm), By Mode of Purchase, By Country and Growth Forecast, 2023 - 2030


The North America Pen Needles Market would witness market growth of 8.0% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 23,907.7 thousand Units, showcasing a growth of 8.0% (2019-2022).

Safety concerns are a significant restraint of the market. One of the main concerns is the risk of accidental needlestick injuries, which can occur when the needle is not properly disposed of or when it accidentally punctures the skin of a healthcare worker or another person. This can lead to the transfer of bloodborne pathogens like hepatitis B, hepatitis C, and HIV. Thus, proper disposal of used pen needles is essential to minimize the risk of accidental needlestick injuries and prevent the spread of infectious diseases.

As more individuals are diagnosed with diabetes, there is a growing demand for insulin pens and the associated pen needles. It offers a more convenient and discreet insulin administration than traditional vial and syringe methods. Safety features like needle shields to prevent needlestick injuries have also contributed to the market's growth. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and requirements for the safety and efficacy of pen needles, increasing the quality of these devices. Growing awareness of the importance of diabetes management and the availability of user-friendly insulin delivery devices, like insulin pens, have led to increased adoption.

According to the National Library of Medicine, in 2020, more than 30 million people in the United States lived with diabetes. Over 15% of people living with diabetes use insulin therapy. The growing adoption of insulin therapy in the United States is a crucial driver for the pen needles market, as more individuals require insulin for diabetes management. This trend has led to innovation in pen needle design, ensuring better patient comfort and safety during injections. As diabetes management continues to be a priority in the U.S. healthcare system, the demand for pen needles is expected to remain strong. Due to the elements mentioned above the market will grow significantly in this region.

The US market dominated the North America Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $700.4 million by 2030. The Canada market is exhibiting a CAGR of 10.4% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 9.4% during (2023 - 2030).

Based on Type, the market is segmented into Standard Pen Needles, and Safety Pen Needles. Based on Setting, the market is segmented into Homecare, Hospitals & Clinics, and Others. Based on Application, the market is segmented into Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone, Osteoporosis, and Others. Based on Length, the market is segmented into 8mm, 6mm, 5mm, 10mm, 12mm, and 4mm. Based on Mode of Purchase, the market is segmented into Over the Counter, Prescription-based, Online Purchase, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Embecta Corp., Novo Nordisk A/S, Ypsomed AG, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Limited, Arkray, Inc., UltiMed, Inc. and Allison Medical, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Standard Pen Needles
  • Safety Pen Needles
By Setting (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Homecare
  • Hospitals & Clinics
  • Others
By Application (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Insulin
  • Glucagon-like-Peptide-1 (GLP-1)
  • Growth Hormone
  • Osteoporosis
  • Others
By Length
  • 8mm
  • 6mm
  • 5mm
  • 10mm
  • 12mm
  • 4mm
By Mode of Purchase (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Over the Counter
  • Prescription-based
  • Online Purchase
  • Others
By Country (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Embecta Corp.
  • Novo Nordisk A/S
  • Ypsomed AG
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Owen Mumford Limited
  • Arkray, Inc.
  • UltiMed, Inc.
  • Allison Medical, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

178 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pen Needles Market, by Type
1.4.2 North America Pen Needles Market, by Setting
1.4.3 North America Pen Needles Market, by Application
1.4.4 North America Pen Needles Market, by Length
1.4.5 North America Pen Needles Market, by Mode of Purchase
1.4.6 North America Pen Needles Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Market Share Analysis, 2022
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, Feb – 2023, Sep) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Pen Needles Market by Type
5.1 North America Standard Pen Needles Market by Region
5.2 North America Safety Pen Needles Market by Region
Chapter 6. North America Pen Needles Market by Setting
6.1 North America Homecare Market by Country
6.2 North America Hospitals & Clinics Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Pen Needles Market by Application
7.1 North America Insulin Market by Country
7.2 North America Glucagon-like-Peptide-1 (GLP-1) Market by Country
7.3 North America Growth Hormone Market by Country
7.4 North America Osteoporosis Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Pen Needles Market by Length
8.1 North America 8mm Market by Country
8.2 North America 6mm Market by Country
8.3 North America 5mm Market by Country
8.4 North America 10mm Market by Country
8.5 North America 12mm Market by Country
8.6 North America 4mm Market by Country
Chapter 9. North America Pen Needles Market by Mode of Purchase
9.1 North America Over the Counter Market by Country
9.2 North America Prescription-based Market by Country
9.3 North America Online Purchase Market by Country
9.4 North America Others Market by Country
Chapter 10. North America Pen Needles Market by Country
10.1 US Pen Needles Market
10.1.1 US Pen Needles Market by Type
10.1.2 US Pen Needles Market by Setting
10.1.3 US Pen Needles Market by Application
10.1.4 US Pen Needles Market by Length
10.1.5 US Pen Needles Market by Mode of Purchase
10.2 Canada Pen Needles Market
10.2.1 Canada Pen Needles Market by Type
10.2.2 Canada Pen Needles Market by Setting
10.2.3 Canada Pen Needles Market by Application
10.2.4 Canada Pen Needles Market by Length
10.2.5 Canada Pen Needles Market by Mode of Purchase
10.3 Mexico Pen Needles Market
10.3.1 Mexico Pen Needles Market by Type
10.3.2 Mexico Pen Needles Market by Setting
10.3.3 Mexico Pen Needles Market by Application
10.3.4 Mexico Pen Needles Market by Length
10.3.5 Mexico Pen Needles Market by Mode of Purchase
10.4 Rest of North America Pen Needles Market
10.4.1 Rest of North America Pen Needles Market by Type
10.4.2 Rest of North America Pen Needles Market by Setting
10.4.3 Rest of North America Pen Needles Market by Application
10.4.4 Rest of North America Pen Needles Market by Length
10.4.5 Rest of North America Pen Needles Market by Mode of Purchase
Chapter 11. Company Profiles
11.1 Embecta Corp.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Owen Mumford Limited
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.2.3 SWOT Analysis
11.3 Novo Nordisk A/S
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental & Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Acquisition and Mergers:
11.3.5.3 Geographical Expansions:
11.3.6 SWOT Analysis
11.4 Ypsomed AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Recent strategies and developments:
11.4.4.1 Partnerships, Collaborations, and Agreements:
11.4.4.2 Product Launches and Product Expansions:
11.4.5 SWOT Analysis
11.5 B. Braun Melsungen AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Terumo Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental and Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Partnerships, Collaborations, and Agreements:
11.6.5.2 Product Launches and Product Expansions:
11.6.6 SWOT Analysis
11.7 Nipro Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.8 Arkray, Inc.
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 UltiMed, Inc.
11.9.1 Company Overview
11.10. Allison Medical, Inc.
11.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us